Скачать или смотреть PrimeTalk: Redefining Indian pharma - through the lens of young leaders

From operating puny units in the 1990s, leading Indian pharmaceutical companies have seen a dream run. Industry leaders like Yusuf Hamied, Dilip Shanghvi, and Pankaj Patel did what they could do best with limited resources. But will that be good enough to grow from here on? Can generic drugs alone fuel growth? Can India ever develop a blockbuster drug — something that has been elusive for so long? That’s where young leaders come in — unlearning and learning as they think differently on how to do things. Let’s try and understand how young minds are working and challenging the status quo.

ET Prime’s pharma and healthcare editor, Vikas Dandekar spoke to our panelists:
Sharvil Patel, managing director, Zydus Cadila
Namita Thapar, executive director, Emcure Pharmaceutical
Arjun Juneja, chief operating officer, Mankind
Aman Mehta, chief marketing officer, Torrent Pharma

Chapters:
00:00 - Introduction
03:15 - Learning and unlearning
36:10 - Future of pharma research
39:00 - Role of innovation and technology
48:10 - The next big step
1:10:45 - Q&A session